Sign in
4

Changes in Ownership

Perspective Therapeutics, Inc. Filed Acc 0001437749-23-034931

Chief Medical Officer bought 595,425 shares at an average $0.32 ($188,737)

From the SEC's structured data for this filing

Trades in this filing

Puhlmann Markus · Chief Medical Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2023-12-15 Purchase : show line 1 in the form +135,006 $0.27 $36,276 635,006 D
2023-12-18 Purchase : show line 2 in the form +60,419 $0.26 $15,461 695,425 D
2023-12-19 Purchase : show line 3 in the form +400,000 $0.34 $137,000 1,095,425 D
Open-market purchases · 595,425 sh · avg $0.32 · $188,737
Loading xslF345X05/rdgdoc.xml…